文献速递儿童青少年精神

Shank3相关自闭症少突胶质细胞改变可经Erk通路抑制恢复

Shank3 related oligodendrocyte alterations in autism are restored by Erk pathway inhibition.
PubMed 文献 · Mol Psychiatry · 2025-11-07

该研究在Shank3缺陷模型中揭示少突胶质细胞发育障碍:前体细胞增殖增加而成熟与髓鞘化受损,机制涉及Erk通路过度激活及Wnt5a上调。药物抑制Erk通路可恢复体外成熟、改善体内髓鞘缺陷并部分改善自闭症相关行为与运动功能。

要点

  • Shank3缺陷导致少突胶质前体细胞增殖增加但成熟和髓鞘化受损。
  • Erk通路过度激活介导少突胶质细胞成熟障碍和髓鞘形成不足。
  • 抑制Erk通路可恢复髓鞘化并部分改善Shank3缺陷小鼠行为。

核心结论

  • Wnt5a-Erk轴是Shank3相关自闭症少突胶质细胞功能障碍的关键调节通路,抑制Erk通路具有治疗白质缺陷的潜力。

研究设计与样本

  • 研究采用Shank3缺陷模型,结合体外少突胶质细胞实验、体内髓鞘化评估、行为学测试及转录组分析。

主要发现

  • Shank3缺陷促进少突胶质前体细胞增殖并损害其功能成熟与髓鞘化。
  • Shank3缺陷诱导Erk信号通路过度激活,损害少突胶质细胞成熟并导致髓鞘形成不足。
  • 药物抑制Erk通路恢复体外少突胶质细胞成熟、挽救体内髓鞘化缺陷并部分改善自闭症相关行为和运动功能。
  • 转录组分析显示Shank3缺陷少突胶质细胞中Wnt信号失调,非经典Wnt通路关键配体Wnt5a上调。
  • Wnt5a处理可激活原代少突胶质细胞Erk信号并重现髓鞘化缺陷。

临床怎么用

  • Erk通路抑制可能作为改善Shank3相关自闭症白质缺陷的潜在治疗策略。
  • Wnt5a-Erk轴可作为少突胶质细胞功能障碍的干预靶点进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

White matter abnormalities are consistently observed in Shank3-related autism spectrum disorders (ASD), yet the mechanisms underlying oligodendrocyte dysfunction and myelination deficits remain poorly characterized. Here, we demonstrate that Shank3 deficiency disrupts oligodendrocyte development by promoting oligodendrocyte precursor cell (OPC) proliferation while impairing functional maturation and myelination. Mechanistically, Shank3 deficiency induced hyperactivation of the Erk signalling pathway, which compromised oligodendrocyte maturation and contributes to hypomyelination. Pharmacological inhibition of the Erk pathway effectively restored oligodendrocyte maturation in vitro, rescued myelination deficits in vivo, and partially improved autism-related behaviors and motor function in Shank3-deficient mice. Transcriptomic analyses furtherly revealed dysregulation of Wnt signalling, particularly the upregulation of Wnt5a, a key ligand of the non-canonical Wnt pathway, in Shank3-deficient oligodendrocytes. Consistently, Wnt5a treatment was found to activate Erk signalling in primary oligodendrocytes and replicate the observed myelination deficits. These findings uncover the Wnt5a-Erk axis as a critical regulator of oligodendrocyte dysfunction in Shank3-related ASD and highlight its therapeutic potential for addressing associated white matter deficits.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Ma Y, Bauer HF, Bockmann J, et al. Shank3 related oligodendrocyte alterations in autism are restored by Erk pathway inhibition. Mol Psychiatry. 2025. PMID: 41203933. doi:10.1038/s41380-025-03333-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。